The tactics of treatment of sclerites of rheumatoid genesis
Inflammatory lesions of the sclera have a recurring course with a wide range of clinical manifestations and are hard to treat by medications. Purpose: to develop a combined therapy pattern with the use of medications Broxinac® (bromfenac) and Visallergol (olopatadine 0.2 %) in patients with sclerite...
| Main Authors: | E. V. Yani, E. S. Vakhova, K. E. Seliverstova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Real Time Ltd
2018-10-01
|
| Series: | Российский офтальмологический журнал |
| Subjects: | |
| Online Access: | https://roj.igb.ru/jour/article/view/144 |
Similar Items
-
Clinical Experience of Using 0.2 % Olopatadin in the Allergic Conjunctivitis Treatment
by: S. V. Yanchenko, et al.
Published: (2019-10-01) -
Use of bromfenac 0.09% (Broksinak) in the complex therapy for HLA-B27-associated anterior uveitis
by: Oleksandra Zborovska
Published: (2024-04-01) -
Association of Protective HLA-A With HLA-B∗27 Positive Ankylosing Spondylitis
by: Jessika Nordin, et al.
Published: (2021-07-01) -
Genetic markers for psoriatic arthritis among patients with psoriasis. Part II: HLA genes
by: A. A. Kubanov, et al.
Published: (2021-12-01) -
Large refrigerant capacity induced by table-like magnetocaloric effect in amorphous Er0.2Gd0.2Ho0.2Co0.2Cu0.2 ribbons
by: Lingwei Li, et al.
Published: (2018-08-01)